Ozarium (Losartan Potassium)

Losartan potassium blocks the AT‑1 receptors that bind angiotensin II, preventing the hormone from causing blood‑vessel narrowing and aldosterone release. This results in relaxed blood vessels, reduced fluid retention and lower blood pressure.

The dose of Ozarium is individualized by a prescriber based on the patient’s blood‑pressure goals, kidney function and other clinical factors. Only a qualified health‑care professional should determine the appropriate regimen.

Losartan potassium is not recommended in the second or third trimester of pregnancy because it can harm the developing fetus. Limited data exist for breastfeeding, so the benefits and risks should be evaluated by a health‑care provider.

To order, submit an enquiry on the Ozarium product page at gnhindia.com, providing the required quantity and your institutional credentials. GNH India works with hospitals, pharmacies and procurement teams worldwide, then replies with pricing, availability, shipping details and any necessary import documentation.

Ozarium (losartan) is one of several ARBs; it shares the class‑wide benefit of blocking angiotensin II receptors but differs in dosing frequency, half‑life and specific evidence for kidney protection. Clinicians may choose losartan over alternatives based on patient comorbidities, tolerability and guideline recommendations.

Store Ozarium tablets at temperatures below 25 °C in the original container, protecting them from moisture and direct light. Do not use the product if the packaging is damaged or the tablets appear discoloured.

Ozarium is taken orally, usually once daily, with or without food. Patients should follow the prescribing clinician’s instructions regarding timing and whether the tablet should be swallowed whole or split.

Serious adverse events can include hyperkalemia, acute kidney injury, angio‑edema and severe hypotension. Patients should seek immediate medical attention if they experience swelling of the face or throat, rapid heartbeat, dizziness, or unexplained weakness.

Ozarium is contraindicated in individuals with known hypersensitivity to losartan or any ARB, in patients with severe liver impairment, and in pregnant women during the second and third trimesters. Caution is also advised for those with significant renal dysfunction.